TABLE 7.
Ultrasound imaging to estimate fatty infiltration of the liver in participants in the two groups, berberine (B) and control (C), at enrolment and after 90 days of treatment.
| Liver ultrasound | B–baseline | C–baseline | B–90 days | C–90 days |
|---|---|---|---|---|
| Number of subjects, n | 26 | 35 | 25 | 32 |
| Normal, n (%) | 21 (80.8%) | 21 (60.0%) | 23 (92.0%) | 25 (78.1%) |
| NAFLD, n (%) | 5 (19.2%) | 14 (40.0%) | 2 (8.0%) | 2 (8.0%) |
| p between “baseline” values: 0.0832 between “90 days” values: 0.1413 | ||||
NAFLD, Non-Alcoholic Fatty Liver Disease.